Optimized Hydroxypropyl-Beta-Cyclodextrin Oral Patch for Anaerobic Infections
ProcurenetShort description
The Hydroxypropyl-Beta-Cyclodextrin Oral Patch is an innovative therapeutic application for the treatment of anaerobic bacterial infections, especially those localized in the oral cavity. The product is built with a sustained-release mechanism, providing prolonged and effective treatment. The patch includes Metronidazole as the active ingredient and Hydroxypropyl-Beta-Cyclodextrin for stability and controlled release of drug components. The product also offers a significant monthly production capacity and can be customized according to packaging needs. Storage and handling require a cool, dry place away from direct sunlight and extreme temperatures.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
The Application of Hydroxypropyl-Beta-Cyclodextrin in Oral Patch for Anaerobic Bacterial Infections is a groundbreaking solution for periodontal and other anaerobic infections. The core components include Hydroxypropyl-Beta-Cyclodextrin and Metronidazole, delivering potent anti-anaerobic bacteria properties.
- Hydroxypropyl-Beta-Cyclodextrin, a vital binder in this oral patch, aids in creating a sustained-release system for the active ingredient, Metronidazole.
- Metronidazole is the first drug of choice against anti-anaerobic bacteria, functioning by both inhibiting and killing these harmful pathogens. Its definite therapeutic mechanism involves reducing anaerobic bacteria, generating cytotoxic substances, and inhibiting the DNA synthesis of sensitive bacteria. This makes it an effective tool in periodontal health management.
- The artificial bezoar Metronidazole oral patch can be either a double or single-layer patch, offering effective and sustained delivery of the medicament. With Hydroxypropyl-Beta-Cyclodextrin, it optimizes transmucosal drug delivery, reducing the frequency of administration and enhancing the drug's overall utility.
The product is crafted to meet the highest standards, delivered in safe and customizable packages. The oral patch's grade is optimized for injection, meticulously formulated to assure quality, efficacy, and safety.
- Shipping capabilities extend across North and South America, Western and Eastern Europe, Australasia, Asia, and the Middle East, with a substantial monthly production capacity of 100,000,000 kg.
- With contract manufacturing options, you can leverage our extensive capacity for CRO and CMO.
- Packaging is both customizable and business-focused, available in 500g/bag, 1kg/bag, 10kg/drum, and 20kg/drum packaging options.
